ZIM Laboratories has received approval for Investment of upto Euro 1,53,000 in the equity shares of SIA ZIM Laboratories, wholly owned subsidiary of the company. The investment in equity shares of SIA ZIM Laboratories is with an objective of expansion and development of business in the European region.
The company has also received approval for incorporation of a subsidiary of ZIM Laboratories FZE, Sharjah (Wholly owned subsidiary of the Company). Post investment, the newly incorporated subsidiary would be a step-down subsidiary of the Company. The incorporation of step down subsidiary is with an objective of expansion and development of business in the MENA region. The Board of Directors of the company in their meeting held on August 3, 2024, has approved the same.
ZIM Laboratories manufactures, formulates, and distributes drug delivery systems to develop generic pharmaceutical products.
Company Name | CMP |
---|---|
Sun Pharma Inds. | 1808.50 |
Dr. Reddys Lab | 1342.45 |
Cipla | 1472.45 |
Lupin | 2147.55 |
Zydus Lifesciences | 973.90 |
View more.. |